9h
Nurix Therapeutics Highlights STAT6, BTK and IRAK4 Degraders as Immunology Pipeline Gains Spotlight
Executives from Nurix Therapeutics (NASDAQ:NRIX) used a recent discussion on the company’s immunology and inflammation (I&I) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results